Preview Mode Links will not work in preview mode

blooducation's podcast

Jan 22, 2021

Anticoagulation dilemmas with Dr Gill Lowe





Feb 10, 2020

CAR-T = Chimeric Antigen Receptor T cells; T cells genetically modified and “retrained” to recognise an antigen present on cancer cells. CAR-T cells currently in use are against CD19 but any antigen could be a potential target